Publication: Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease
Issued Date
2009-04-01
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-65649153745
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.92, No.4 (2009), 548-555
Suggested Citation
Pornpim Korpraphong, John R. Leyendecker, Charles F. Hildebolt, Vamsri Narra, Klongtae Ty Bae, Jeffrey J. Brown Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease. Journal of the Medical Association of Thailand. Vol.92, No.4 (2009), 548-555. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/28134
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease
Abstract
Objective: To determine the significance of small arterially-enhancing liver lesions seen with magnetic resonance imaging (MRI) in patients with chronic liver disease. Material and Method: Our institutional review board approved this retrospective study, without requiring informed consent. Over a two-year period, 258 consecutive patients with cirrhosis or chronic hepatitis underwent multiphase three-dimensional, gadolinium-enhanced, breath-hold gradient-echo MRI. From this group, 29 patients underwent at least one follow-up MR study. When a small (≤ 20 mm) arterially-enhancing lesion was detected, the maximum diameter, shape, signal intensities (T1-weighted and T2-weighted), and pattern of enhancement were evaluated to assess the associations between the imaging appearance on initial MR exam and subsequent behavior on follow-up imaging. Statistical testing was performed with JMP Statistical Software (SAS, Inc., Cary, NC) and StatXact 7 Statistical Software for Exact Nonparmetric Inference (Cytel, Inc. Cambride, MA). Results: Sixty-five small (≤ 20 mm) arterially-enhancing lesions were detected in 29 patients. Ten of 65 lesions (15%) in nine patients were subsequently proven to represent hepatocellular carcinoma (HCC), while the remaining lesions either disappeared (46) or remained stable in size (9). Of the 10 lesions subsequently proven to represent HCC, eight lesions converted from hypo- or isointense to hyperintense on subsequent T2-weighted MRI (p < 0.001), seven lesions converted from hyper- or isointense to hypointense on subsequent T1-weighted images (p < 0.001), seven lesions demonstrated growth on subsequent MRI exam (mean increase in mean diameter = 1.4 cm), and five lesions subsequently developed rim enhancement that was not initially present. Conclusion: Small, arterially-enhancing lesions detected with MRI have a low likelihood of representing HCC, and MRI follow-up of such lesions is a reasonable approach. Lesions that increase in size, convert to hypointense on subsequent T1W images, convert to hyperintense in T2W images, or develop rim enhancement on follow-up MRI images are concerning and should prompt consideration of intervention.